ClinicalTrials.Veeva

Menu

Neurophysiological Validation of the Clinical Criteria of Sensitization in Chronic Pelvic and Perineal Pain Population (DOPEC)

N

Nantes University Hospital (NUH)

Status

Terminated

Conditions

Chronic Pelvic Pain
Chronic Perineal Pain

Treatments

Other: Sensory testing of lower rectal tract
Other: Sensory testing of vulva muscles
Other: Sensory testing of pelvic muscles
Other: Sensory testing of lower urinary tract.

Study type

Interventional

Funder types

Other

Identifiers

NCT03541954
RC17_0427

Details and patient eligibility

About

The purpose of this study is to assess and validate the clinical criteria of sensitization ("Convergences PP criteria") selected by the expert consensus with neurophysiological sensory testing.

Full description

Some patient with chronic pelvic or perineal pain, present complex manifestations, comprising pain and dysfunction which does not involved a single organ. The gap between clinical symptoms and pathological signs is a constant feature of these pain syndromes. A possible explanation for these pain syndromes is central sensitization. This sensitization is defined by decrease nociceptive thresholds, a more intense and more prolonged response to nociceptive stimulus, and spatial extension of the painful area. It has been defined by international expert consensus in 2016 a clinical evaluation tool with 10 criteria for sensitization diagnosis: Convergences PP criteria. The aim of this study is to objectivize lower threshold, spatial and temporal diffusion of pain in women with chronic pelvic or perineal pain with sensitization (Convergences PP criteria > 5) compared to women without sensitization (Convergences PP criteria < 5). A sensory testing of lower urinary tract, lower rectal tract, vulva and pelvic muscles will be achieved.

Enrollment

60 patients

Sex

Female

Ages

25+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women > 25 years,
  • Pelvic or perineal pain since > 3 months,
  • No injury in pelvic imagery or clinical examination that may explain all the pain complaint,
  • Patient who can understand the protocol,
  • Patient who agreed and signed the informed consent for participation.

Exclusion criteria

  • Poor understanding of French language,
  • Pregnancy or lactation,
  • Severe depression (Beck Depression Inventory-Short form > 16),
  • Initial pain estimation at 10 on numeric analog scale,
  • Inadequately cooperating,
  • Isolated dysmenorrhea,
  • Deep endometriosis with rectal or bladder lesion,
  • Genital or bladder infection,
  • Urogenital tumor history,
  • Anorectal surgery history a type of digestive resection,
  • Anal stenosis,
  • Advanced vaginal prolapse (stage 2 on POP-Q scale),
  • Post-traumatic stress disorder history,
  • Deprived of liberty (trusteeship, guardianship).

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups

Patient with pelvic or perineal pain with sensitization
Other group
Description:
Patients with chronic pelvic or perineal pain with sensitization (Convergences PP criteria \> 5)
Treatment:
Other: Sensory testing of lower urinary tract.
Other: Sensory testing of pelvic muscles
Other: Sensory testing of vulva muscles
Other: Sensory testing of lower rectal tract
Patient with pelvic or perineal pain without sensitization
Other group
Description:
Patients with chronic pelvic or perineal pain without sensitization (Convergences PP criteria \< 5)
Treatment:
Other: Sensory testing of lower urinary tract.
Other: Sensory testing of pelvic muscles
Other: Sensory testing of vulva muscles
Other: Sensory testing of lower rectal tract

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems